Cabozantinib versus everolimus in advanced renal-cell carcinoma

Toni K. Choueiri, Bernard Escudier, Thomas Powles, Paul N. Mainwaring, Brian I. Rini, Frede Donskov, Hans Hammers, Thomas E. Hutson, Jae Lyun Lee, Katriina Peltola, Bruce J. Roth, Georg A. Bjarnason, Lajos Geczi, Bhumsuk Keam, Pablo Maroto, Daniel Y.C. Heng, Manuela Schmidinger, Philip W. Kantoff, Anne Borgman-Hagey, Colin HesselChristian Scheffold, Gisela M. Schwab, Nizar M. Tannir, Robert J. Motzer

Research output: Contribution to journalArticlepeer-review

798 Scopus citations

Fingerprint

Dive into the research topics of 'Cabozantinib versus everolimus in advanced renal-cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences